Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.550
+0.010 (0.28%)
At close: Jun 27, 2025, 4:00 PM
3.700
+0.150 (4.23%)
After-hours: Jun 27, 2025, 6:35 PM EDT
Qualigen Therapeutics Market Cap
Qualigen Therapeutics has a market cap or net worth of $2.61 million as of June 27, 2025. Its market cap has increased by 101.10% in one year.
Market Cap
2.61M
Enterprise Value
3.66M
1-Year Change
101.10%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.40M to $2.61M, a decrease of -93.19%. That is a compound annual growth rate of -23.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 2.60M | -16.13% |
| Dec 31, 2024 | 3.10M | 10.71% |
| Dec 29, 2023 | 2.80M | -48.15% |
| Dec 30, 2022 | 5.40M | -82.69% |
| Dec 31, 2021 | 31.20M | -55.04% |
| Dec 31, 2020 | 69.40M | 3,982.35% |
| Dec 31, 2019 | 1.70M | -50.00% |
| Dec 31, 2018 | 3.40M | -79.14% |
| Dec 29, 2017 | 16.30M | -43.99% |
| Dec 30, 2016 | 29.10M | 120.45% |
| Dec 31, 2015 | 13.20M | -65.63% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |